nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP3A5—Paclitaxel—ovarian cancer	0.108	0.194	CbGbCtD
Granisetron—CYP2D6—Vinorelbine—ovarian cancer	0.094	0.169	CbGbCtD
Granisetron—CYP3A4—Topotecan—ovarian cancer	0.0848	0.153	CbGbCtD
Granisetron—CYP3A5—Docetaxel—ovarian cancer	0.0779	0.14	CbGbCtD
Granisetron—CYP3A4—Vinorelbine—ovarian cancer	0.0598	0.108	CbGbCtD
Granisetron—CYP3A4—Paclitaxel—ovarian cancer	0.042	0.0757	CbGbCtD
Granisetron—CYP2D6—Doxorubicin—ovarian cancer	0.0356	0.0642	CbGbCtD
Granisetron—CYP3A4—Docetaxel—ovarian cancer	0.0304	0.0547	CbGbCtD
Granisetron—CYP3A4—Doxorubicin—ovarian cancer	0.0226	0.0408	CbGbCtD
Granisetron—Discomfort—Paclitaxel—ovarian cancer	0.000612	0.00137	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000609	0.00137	CcSEcCtD
Granisetron—Dry mouth—Paclitaxel—ovarian cancer	0.000606	0.00136	CcSEcCtD
Granisetron—Diarrhoea—Vinorelbine—ovarian cancer	0.000604	0.00136	CcSEcCtD
Granisetron—Dysgeusia—Docetaxel—ovarian cancer	0.000604	0.00136	CcSEcCtD
Granisetron—Abdominal distension—Epirubicin—ovarian cancer	0.000601	0.00135	CcSEcCtD
Granisetron—Nausea—Melphalan—ovarian cancer	0.0006	0.00135	CcSEcCtD
Granisetron—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000594	0.00133	CcSEcCtD
Granisetron—Oedema—Paclitaxel—ovarian cancer	0.000594	0.00133	CcSEcCtD
Granisetron—Eosinophilia—Epirubicin—ovarian cancer	0.000591	0.00133	CcSEcCtD
Granisetron—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00059	0.00132	CcSEcCtD
Granisetron—Infection—Paclitaxel—ovarian cancer	0.00059	0.00132	CcSEcCtD
Granisetron—Shock—Paclitaxel—ovarian cancer	0.000584	0.00131	CcSEcCtD
Granisetron—Dizziness—Vinorelbine—ovarian cancer	0.000584	0.00131	CcSEcCtD
Granisetron—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000584	0.00131	CcSEcCtD
Granisetron—Nervous system disorder—Paclitaxel—ovarian cancer	0.000582	0.00131	CcSEcCtD
Granisetron—Hypokalaemia—Doxorubicin—ovarian cancer	0.000581	0.00131	CcSEcCtD
Granisetron—Angina pectoris—Epirubicin—ovarian cancer	0.000581	0.00131	CcSEcCtD
Granisetron—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000581	0.00131	CcSEcCtD
Granisetron—Tachycardia—Paclitaxel—ovarian cancer	0.000579	0.0013	CcSEcCtD
Granisetron—Skin disorder—Paclitaxel—ovarian cancer	0.000577	0.0013	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000575	0.00129	CcSEcCtD
Granisetron—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000574	0.00129	CcSEcCtD
Granisetron—Anaemia—Docetaxel—ovarian cancer	0.00057	0.00128	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000564	0.00127	CcSEcCtD
Granisetron—Vomiting—Vinorelbine—ovarian cancer	0.000561	0.00126	CcSEcCtD
Granisetron—Dysuria—Epirubicin—ovarian cancer	0.000558	0.00125	CcSEcCtD
Granisetron—Rash—Vinorelbine—ovarian cancer	0.000556	0.00125	CcSEcCtD
Granisetron—Dermatitis—Vinorelbine—ovarian cancer	0.000556	0.00125	CcSEcCtD
Granisetron—Abdominal distension—Doxorubicin—ovarian cancer	0.000556	0.00125	CcSEcCtD
Granisetron—Hypotension—Paclitaxel—ovarian cancer	0.000555	0.00125	CcSEcCtD
Granisetron—Headache—Vinorelbine—ovarian cancer	0.000553	0.00124	CcSEcCtD
Granisetron—Syncope—Docetaxel—ovarian cancer	0.000553	0.00124	CcSEcCtD
Granisetron—Leukopenia—Docetaxel—ovarian cancer	0.000552	0.00124	CcSEcCtD
Granisetron—Eosinophilia—Doxorubicin—ovarian cancer	0.000547	0.00123	CcSEcCtD
Granisetron—Palpitations—Docetaxel—ovarian cancer	0.000545	0.00122	CcSEcCtD
Granisetron—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000545	0.00122	CcSEcCtD
Granisetron—Loss of consciousness—Docetaxel—ovarian cancer	0.000542	0.00122	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000541	0.00121	CcSEcCtD
Granisetron—Cough—Docetaxel—ovarian cancer	0.000538	0.00121	CcSEcCtD
Granisetron—Angina pectoris—Doxorubicin—ovarian cancer	0.000538	0.00121	CcSEcCtD
Granisetron—Insomnia—Paclitaxel—ovarian cancer	0.000537	0.00121	CcSEcCtD
Granisetron—Paraesthesia—Paclitaxel—ovarian cancer	0.000533	0.0012	CcSEcCtD
Granisetron—Hypertension—Docetaxel—ovarian cancer	0.000532	0.0012	CcSEcCtD
Granisetron—Dyspnoea—Paclitaxel—ovarian cancer	0.000529	0.00119	CcSEcCtD
Granisetron—Somnolence—Paclitaxel—ovarian cancer	0.000528	0.00119	CcSEcCtD
Granisetron—Arthralgia—Docetaxel—ovarian cancer	0.000525	0.00118	CcSEcCtD
Granisetron—Chest pain—Docetaxel—ovarian cancer	0.000525	0.00118	CcSEcCtD
Granisetron—Nausea—Vinorelbine—ovarian cancer	0.000524	0.00118	CcSEcCtD
Granisetron—Dyspepsia—Paclitaxel—ovarian cancer	0.000523	0.00117	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000521	0.00117	CcSEcCtD
Granisetron—Jaundice—Epirubicin—ovarian cancer	0.000519	0.00116	CcSEcCtD
Granisetron—Urinary tract infection—Epirubicin—ovarian cancer	0.000517	0.00116	CcSEcCtD
Granisetron—Dysuria—Doxorubicin—ovarian cancer	0.000516	0.00116	CcSEcCtD
Granisetron—Decreased appetite—Paclitaxel—ovarian cancer	0.000516	0.00116	CcSEcCtD
Granisetron—Dry mouth—Docetaxel—ovarian cancer	0.000513	0.00115	CcSEcCtD
Granisetron—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000513	0.00115	CcSEcCtD
Granisetron—Sweating—Epirubicin—ovarian cancer	0.00051	0.00115	CcSEcCtD
Granisetron—Pain—Paclitaxel—ovarian cancer	0.000508	0.00114	CcSEcCtD
Granisetron—Constipation—Paclitaxel—ovarian cancer	0.000508	0.00114	CcSEcCtD
Granisetron—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000504	0.00113	CcSEcCtD
Granisetron—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000503	0.00113	CcSEcCtD
Granisetron—Anaphylactic shock—Docetaxel—ovarian cancer	0.000503	0.00113	CcSEcCtD
Granisetron—Oedema—Docetaxel—ovarian cancer	0.000503	0.00113	CcSEcCtD
Granisetron—Epistaxis—Epirubicin—ovarian cancer	0.000502	0.00113	CcSEcCtD
Granisetron—Infection—Docetaxel—ovarian cancer	0.0005	0.00112	CcSEcCtD
Granisetron—Sinusitis—Epirubicin—ovarian cancer	0.000499	0.00112	CcSEcCtD
Granisetron—Shock—Docetaxel—ovarian cancer	0.000495	0.00111	CcSEcCtD
Granisetron—Nervous system disorder—Docetaxel—ovarian cancer	0.000493	0.00111	CcSEcCtD
Granisetron—Thrombocytopenia—Docetaxel—ovarian cancer	0.000493	0.00111	CcSEcCtD
Granisetron—Tachycardia—Docetaxel—ovarian cancer	0.000491	0.0011	CcSEcCtD
Granisetron—Feeling abnormal—Paclitaxel—ovarian cancer	0.000489	0.0011	CcSEcCtD
Granisetron—Skin disorder—Docetaxel—ovarian cancer	0.000489	0.0011	CcSEcCtD
Granisetron—Bradycardia—Epirubicin—ovarian cancer	0.000486	0.00109	CcSEcCtD
Granisetron—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000485	0.00109	CcSEcCtD
Granisetron—Jaundice—Doxorubicin—ovarian cancer	0.00048	0.00108	CcSEcCtD
Granisetron—Rhinitis—Epirubicin—ovarian cancer	0.000479	0.00108	CcSEcCtD
Granisetron—Urinary tract infection—Doxorubicin—ovarian cancer	0.000479	0.00107	CcSEcCtD
Granisetron—Sweating—Doxorubicin—ovarian cancer	0.000472	0.00106	CcSEcCtD
Granisetron—Urticaria—Paclitaxel—ovarian cancer	0.000472	0.00106	CcSEcCtD
Granisetron—Hypotension—Docetaxel—ovarian cancer	0.00047	0.00106	CcSEcCtD
Granisetron—Connective tissue disorder—Epirubicin—ovarian cancer	0.000469	0.00105	CcSEcCtD
Granisetron—Abdominal pain—Paclitaxel—ovarian cancer	0.000469	0.00105	CcSEcCtD
Granisetron—Body temperature increased—Paclitaxel—ovarian cancer	0.000469	0.00105	CcSEcCtD
Granisetron—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000466	0.00105	CcSEcCtD
Granisetron—Epistaxis—Doxorubicin—ovarian cancer	0.000464	0.00104	CcSEcCtD
Granisetron—Sinusitis—Doxorubicin—ovarian cancer	0.000462	0.00104	CcSEcCtD
Granisetron—Visual impairment—Epirubicin—ovarian cancer	0.00046	0.00103	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000458	0.00103	CcSEcCtD
Granisetron—Insomnia—Docetaxel—ovarian cancer	0.000455	0.00102	CcSEcCtD
Granisetron—Paraesthesia—Docetaxel—ovarian cancer	0.000452	0.00101	CcSEcCtD
Granisetron—Bradycardia—Doxorubicin—ovarian cancer	0.00045	0.00101	CcSEcCtD
Granisetron—Dyspnoea—Docetaxel—ovarian cancer	0.000449	0.00101	CcSEcCtD
Granisetron—Somnolence—Docetaxel—ovarian cancer	0.000447	0.001	CcSEcCtD
Granisetron—Flushing—Epirubicin—ovarian cancer	0.000443	0.000996	CcSEcCtD
Granisetron—Rhinitis—Doxorubicin—ovarian cancer	0.000443	0.000995	CcSEcCtD
Granisetron—Dyspepsia—Docetaxel—ovarian cancer	0.000443	0.000995	CcSEcCtD
Granisetron—Decreased appetite—Docetaxel—ovarian cancer	0.000437	0.000982	CcSEcCtD
Granisetron—Hypersensitivity—Paclitaxel—ovarian cancer	0.000437	0.000982	CcSEcCtD
Granisetron—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000434	0.000976	CcSEcCtD
Granisetron—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000434	0.000976	CcSEcCtD
Granisetron—Angiopathy—Epirubicin—ovarian cancer	0.000433	0.000973	CcSEcCtD
Granisetron—Pain—Docetaxel—ovarian cancer	0.00043	0.000966	CcSEcCtD
Granisetron—Constipation—Docetaxel—ovarian cancer	0.00043	0.000966	CcSEcCtD
Granisetron—Chills—Epirubicin—ovarian cancer	0.000429	0.000963	CcSEcCtD
Granisetron—Arrhythmia—Epirubicin—ovarian cancer	0.000427	0.000958	CcSEcCtD
Granisetron—Visual impairment—Doxorubicin—ovarian cancer	0.000426	0.000957	CcSEcCtD
Granisetron—Asthenia—Paclitaxel—ovarian cancer	0.000426	0.000957	CcSEcCtD
Granisetron—Alopecia—Epirubicin—ovarian cancer	0.000422	0.000948	CcSEcCtD
Granisetron—Pruritus—Paclitaxel—ovarian cancer	0.00042	0.000943	CcSEcCtD
Granisetron—Malnutrition—Epirubicin—ovarian cancer	0.000416	0.000934	CcSEcCtD
Granisetron—Feeling abnormal—Docetaxel—ovarian cancer	0.000415	0.000931	CcSEcCtD
Granisetron—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000411	0.000924	CcSEcCtD
Granisetron—Flushing—Doxorubicin—ovarian cancer	0.00041	0.000921	CcSEcCtD
Granisetron—Flatulence—Epirubicin—ovarian cancer	0.00041	0.00092	CcSEcCtD
Granisetron—Tension—Epirubicin—ovarian cancer	0.000408	0.000916	CcSEcCtD
Granisetron—Dysgeusia—Epirubicin—ovarian cancer	0.000407	0.000915	CcSEcCtD
Granisetron—Diarrhoea—Paclitaxel—ovarian cancer	0.000406	0.000912	CcSEcCtD
Granisetron—Nervousness—Epirubicin—ovarian cancer	0.000404	0.000907	CcSEcCtD
Granisetron—Angiopathy—Doxorubicin—ovarian cancer	0.000401	0.000901	CcSEcCtD
Granisetron—Abdominal pain—Docetaxel—ovarian cancer	0.000398	0.000893	CcSEcCtD
Granisetron—Body temperature increased—Docetaxel—ovarian cancer	0.000398	0.000893	CcSEcCtD
Granisetron—Chills—Doxorubicin—ovarian cancer	0.000397	0.000891	CcSEcCtD
Granisetron—Arrhythmia—Doxorubicin—ovarian cancer	0.000395	0.000887	CcSEcCtD
Granisetron—Dizziness—Paclitaxel—ovarian cancer	0.000393	0.000882	CcSEcCtD
Granisetron—Alopecia—Doxorubicin—ovarian cancer	0.000391	0.000877	CcSEcCtD
Granisetron—Ill-defined disorder—Epirubicin—ovarian cancer	0.000386	0.000867	CcSEcCtD
Granisetron—Malnutrition—Doxorubicin—ovarian cancer	0.000385	0.000864	CcSEcCtD
Granisetron—Anaemia—Epirubicin—ovarian cancer	0.000384	0.000863	CcSEcCtD
Granisetron—Agitation—Epirubicin—ovarian cancer	0.000382	0.000858	CcSEcCtD
Granisetron—Flatulence—Doxorubicin—ovarian cancer	0.000379	0.000852	CcSEcCtD
Granisetron—Tension—Doxorubicin—ovarian cancer	0.000378	0.000848	CcSEcCtD
Granisetron—Vomiting—Paclitaxel—ovarian cancer	0.000377	0.000848	CcSEcCtD
Granisetron—Dysgeusia—Doxorubicin—ovarian cancer	0.000377	0.000846	CcSEcCtD
Granisetron—Malaise—Epirubicin—ovarian cancer	0.000375	0.000842	CcSEcCtD
Granisetron—Rash—Paclitaxel—ovarian cancer	0.000374	0.000841	CcSEcCtD
Granisetron—Dermatitis—Paclitaxel—ovarian cancer	0.000374	0.00084	CcSEcCtD
Granisetron—Nervousness—Doxorubicin—ovarian cancer	0.000374	0.000839	CcSEcCtD
Granisetron—Vertigo—Epirubicin—ovarian cancer	0.000374	0.000839	CcSEcCtD
Granisetron—Syncope—Epirubicin—ovarian cancer	0.000373	0.000838	CcSEcCtD
Granisetron—Leukopenia—Epirubicin—ovarian cancer	0.000372	0.000836	CcSEcCtD
Granisetron—Headache—Paclitaxel—ovarian cancer	0.000372	0.000835	CcSEcCtD
Granisetron—Hypersensitivity—Docetaxel—ovarian cancer	0.000371	0.000833	CcSEcCtD
Granisetron—Palpitations—Epirubicin—ovarian cancer	0.000367	0.000825	CcSEcCtD
Granisetron—Loss of consciousness—Epirubicin—ovarian cancer	0.000365	0.000821	CcSEcCtD
Granisetron—Cough—Epirubicin—ovarian cancer	0.000363	0.000815	CcSEcCtD
Granisetron—Asthenia—Docetaxel—ovarian cancer	0.000361	0.000811	CcSEcCtD
Granisetron—Hypertension—Epirubicin—ovarian cancer	0.000359	0.000806	CcSEcCtD
Granisetron—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000357	0.000802	CcSEcCtD
Granisetron—Pruritus—Docetaxel—ovarian cancer	0.000356	0.0008	CcSEcCtD
Granisetron—Anaemia—Doxorubicin—ovarian cancer	0.000356	0.000799	CcSEcCtD
Granisetron—Chest pain—Epirubicin—ovarian cancer	0.000354	0.000795	CcSEcCtD
Granisetron—Arthralgia—Epirubicin—ovarian cancer	0.000354	0.000795	CcSEcCtD
Granisetron—Agitation—Doxorubicin—ovarian cancer	0.000354	0.000794	CcSEcCtD
Granisetron—Anxiety—Epirubicin—ovarian cancer	0.000353	0.000792	CcSEcCtD
Granisetron—Nausea—Paclitaxel—ovarian cancer	0.000353	0.000792	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000352	0.00079	CcSEcCtD
Granisetron—Discomfort—Epirubicin—ovarian cancer	0.00035	0.000786	CcSEcCtD
Granisetron—Malaise—Doxorubicin—ovarian cancer	0.000347	0.000779	CcSEcCtD
Granisetron—Dry mouth—Epirubicin—ovarian cancer	0.000346	0.000778	CcSEcCtD
Granisetron—Vertigo—Doxorubicin—ovarian cancer	0.000346	0.000776	CcSEcCtD
Granisetron—Syncope—Doxorubicin—ovarian cancer	0.000345	0.000775	CcSEcCtD
Granisetron—Leukopenia—Doxorubicin—ovarian cancer	0.000344	0.000774	CcSEcCtD
Granisetron—Diarrhoea—Docetaxel—ovarian cancer	0.000344	0.000773	CcSEcCtD
Granisetron—Palpitations—Doxorubicin—ovarian cancer	0.00034	0.000764	CcSEcCtD
Granisetron—Anaphylactic shock—Epirubicin—ovarian cancer	0.000339	0.000762	CcSEcCtD
Granisetron—Oedema—Epirubicin—ovarian cancer	0.000339	0.000762	CcSEcCtD
Granisetron—Loss of consciousness—Doxorubicin—ovarian cancer	0.000338	0.00076	CcSEcCtD
Granisetron—Infection—Epirubicin—ovarian cancer	0.000337	0.000757	CcSEcCtD
Granisetron—Cough—Doxorubicin—ovarian cancer	0.000336	0.000754	CcSEcCtD
Granisetron—Shock—Epirubicin—ovarian cancer	0.000334	0.00075	CcSEcCtD
Granisetron—Nervous system disorder—Epirubicin—ovarian cancer	0.000333	0.000748	CcSEcCtD
Granisetron—Dizziness—Docetaxel—ovarian cancer	0.000333	0.000747	CcSEcCtD
Granisetron—Thrombocytopenia—Epirubicin—ovarian cancer	0.000332	0.000746	CcSEcCtD
Granisetron—Hypertension—Doxorubicin—ovarian cancer	0.000332	0.000746	CcSEcCtD
Granisetron—Tachycardia—Epirubicin—ovarian cancer	0.000331	0.000744	CcSEcCtD
Granisetron—Skin disorder—Epirubicin—ovarian cancer	0.00033	0.00074	CcSEcCtD
Granisetron—Hyperhidrosis—Epirubicin—ovarian cancer	0.000328	0.000737	CcSEcCtD
Granisetron—Chest pain—Doxorubicin—ovarian cancer	0.000328	0.000736	CcSEcCtD
Granisetron—Arthralgia—Doxorubicin—ovarian cancer	0.000328	0.000736	CcSEcCtD
Granisetron—Anxiety—Doxorubicin—ovarian cancer	0.000326	0.000733	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000325	0.000731	CcSEcCtD
Granisetron—Discomfort—Doxorubicin—ovarian cancer	0.000324	0.000727	CcSEcCtD
Granisetron—Dry mouth—Doxorubicin—ovarian cancer	0.00032	0.00072	CcSEcCtD
Granisetron—Vomiting—Docetaxel—ovarian cancer	0.00032	0.000719	CcSEcCtD
Granisetron—Rash—Docetaxel—ovarian cancer	0.000317	0.000713	CcSEcCtD
Granisetron—Hypotension—Epirubicin—ovarian cancer	0.000317	0.000712	CcSEcCtD
Granisetron—Dermatitis—Docetaxel—ovarian cancer	0.000317	0.000712	CcSEcCtD
Granisetron—Headache—Docetaxel—ovarian cancer	0.000315	0.000708	CcSEcCtD
Granisetron—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000314	0.000705	CcSEcCtD
Granisetron—Oedema—Doxorubicin—ovarian cancer	0.000314	0.000705	CcSEcCtD
Granisetron—Infection—Doxorubicin—ovarian cancer	0.000312	0.000701	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000309	0.000694	CcSEcCtD
Granisetron—Shock—Doxorubicin—ovarian cancer	0.000309	0.000694	CcSEcCtD
Granisetron—Nervous system disorder—Doxorubicin—ovarian cancer	0.000308	0.000692	CcSEcCtD
Granisetron—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000307	0.000691	CcSEcCtD
Granisetron—Insomnia—Epirubicin—ovarian cancer	0.000307	0.000689	CcSEcCtD
Granisetron—Tachycardia—Doxorubicin—ovarian cancer	0.000306	0.000688	CcSEcCtD
Granisetron—Skin disorder—Doxorubicin—ovarian cancer	0.000305	0.000685	CcSEcCtD
Granisetron—Paraesthesia—Epirubicin—ovarian cancer	0.000305	0.000684	CcSEcCtD
Granisetron—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000304	0.000682	CcSEcCtD
Granisetron—Dyspnoea—Epirubicin—ovarian cancer	0.000303	0.00068	CcSEcCtD
Granisetron—Somnolence—Epirubicin—ovarian cancer	0.000302	0.000678	CcSEcCtD
Granisetron—Nausea—Docetaxel—ovarian cancer	0.000299	0.000671	CcSEcCtD
Granisetron—Dyspepsia—Epirubicin—ovarian cancer	0.000299	0.000671	CcSEcCtD
Granisetron—Decreased appetite—Epirubicin—ovarian cancer	0.000295	0.000663	CcSEcCtD
Granisetron—Hypotension—Doxorubicin—ovarian cancer	0.000293	0.000659	CcSEcCtD
Granisetron—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000293	0.000658	CcSEcCtD
Granisetron—Pain—Epirubicin—ovarian cancer	0.00029	0.000652	CcSEcCtD
Granisetron—Constipation—Epirubicin—ovarian cancer	0.00029	0.000652	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000286	0.000643	CcSEcCtD
Granisetron—Insomnia—Doxorubicin—ovarian cancer	0.000284	0.000638	CcSEcCtD
Granisetron—Paraesthesia—Doxorubicin—ovarian cancer	0.000282	0.000633	CcSEcCtD
Granisetron—Dyspnoea—Doxorubicin—ovarian cancer	0.00028	0.000629	CcSEcCtD
Granisetron—Feeling abnormal—Epirubicin—ovarian cancer	0.00028	0.000628	CcSEcCtD
Granisetron—Somnolence—Doxorubicin—ovarian cancer	0.000279	0.000627	CcSEcCtD
Granisetron—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000278	0.000623	CcSEcCtD
Granisetron—Dyspepsia—Doxorubicin—ovarian cancer	0.000276	0.000621	CcSEcCtD
Granisetron—Decreased appetite—Doxorubicin—ovarian cancer	0.000273	0.000613	CcSEcCtD
Granisetron—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000271	0.000609	CcSEcCtD
Granisetron—Urticaria—Epirubicin—ovarian cancer	0.00027	0.000606	CcSEcCtD
Granisetron—Pain—Doxorubicin—ovarian cancer	0.000269	0.000603	CcSEcCtD
Granisetron—Constipation—Doxorubicin—ovarian cancer	0.000269	0.000603	CcSEcCtD
Granisetron—Abdominal pain—Epirubicin—ovarian cancer	0.000268	0.000603	CcSEcCtD
Granisetron—Body temperature increased—Epirubicin—ovarian cancer	0.000268	0.000603	CcSEcCtD
Granisetron—Feeling abnormal—Doxorubicin—ovarian cancer	0.000259	0.000581	CcSEcCtD
Granisetron—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000257	0.000577	CcSEcCtD
Granisetron—Hypersensitivity—Epirubicin—ovarian cancer	0.00025	0.000562	CcSEcCtD
Granisetron—Urticaria—Doxorubicin—ovarian cancer	0.000249	0.00056	CcSEcCtD
Granisetron—Abdominal pain—Doxorubicin—ovarian cancer	0.000248	0.000558	CcSEcCtD
Granisetron—Body temperature increased—Doxorubicin—ovarian cancer	0.000248	0.000558	CcSEcCtD
Granisetron—Asthenia—Epirubicin—ovarian cancer	0.000243	0.000547	CcSEcCtD
Granisetron—Pruritus—Epirubicin—ovarian cancer	0.00024	0.000539	CcSEcCtD
Granisetron—Diarrhoea—Epirubicin—ovarian cancer	0.000232	0.000522	CcSEcCtD
Granisetron—Hypersensitivity—Doxorubicin—ovarian cancer	0.000231	0.00052	CcSEcCtD
Granisetron—Asthenia—Doxorubicin—ovarian cancer	0.000225	0.000506	CcSEcCtD
Granisetron—Dizziness—Epirubicin—ovarian cancer	0.000224	0.000504	CcSEcCtD
Granisetron—Pruritus—Doxorubicin—ovarian cancer	0.000222	0.000499	CcSEcCtD
Granisetron—Vomiting—Epirubicin—ovarian cancer	0.000216	0.000485	CcSEcCtD
Granisetron—Diarrhoea—Doxorubicin—ovarian cancer	0.000215	0.000483	CcSEcCtD
Granisetron—Rash—Epirubicin—ovarian cancer	0.000214	0.000481	CcSEcCtD
Granisetron—Dermatitis—Epirubicin—ovarian cancer	0.000214	0.00048	CcSEcCtD
Granisetron—Headache—Epirubicin—ovarian cancer	0.000213	0.000478	CcSEcCtD
Granisetron—Dizziness—Doxorubicin—ovarian cancer	0.000208	0.000466	CcSEcCtD
Granisetron—Nausea—Epirubicin—ovarian cancer	0.000202	0.000453	CcSEcCtD
Granisetron—Vomiting—Doxorubicin—ovarian cancer	0.0002	0.000448	CcSEcCtD
Granisetron—Rash—Doxorubicin—ovarian cancer	0.000198	0.000445	CcSEcCtD
Granisetron—Dermatitis—Doxorubicin—ovarian cancer	0.000198	0.000444	CcSEcCtD
Granisetron—Headache—Doxorubicin—ovarian cancer	0.000197	0.000442	CcSEcCtD
Granisetron—Nausea—Doxorubicin—ovarian cancer	0.000187	0.000419	CcSEcCtD
